<DOC>
	<DOCNO>NCT02894840</DOCNO>
	<brief_summary>The study aim evaluate safety immunogenicity one dose ( 15 Î¼g HA per strain per dose ) GPO seasonal trivalent inactivate split virion influenza vaccine ( Tri Fluvac ) healthy adult age 18 49 year 90 day post-injection .</brief_summary>
	<brief_title>Safety Immunogenicity GPO Seasonal Trivalent Inactivated Influenza Vaccine Healthy Thai Adults</brief_title>
	<detailed_description>This double blind randomize study consist two phase - Phase I Phase II . The vaccine , seasonal trivalent inactivate split virion influenza vaccine [ A/California/7/2009 , reassortant virus NYMC X-181 ( H1N1 ) , A/Victoria/210/2009 , reassortant virus NYMC X-187 ( H3N2 ) , B/Brisbane/60/2008 , reassortant virus NYMC BX-35 virus strain ] give Phase I Phase II study . The vaccine administer via intramuscular route ; prefer injection site deltoid non-dominant arm . After vaccination volunteer remain clinic least 30 minute observe reactogenicity immunization . Total follow-up 90 day . Blood specimen collect Day 0 prior vaccination , Day 21 , Day 60 , day 90 .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy Age 1849 year old Having Thai ID card equivalent All hematology , biochemistry urine analysis within normal range clinical significance ( high 1.5 time normal value without clinical find history physical examination ) Able read write sign write informed consent form assent form . Known history egg allergy Having recently influenza infection confirm H1N1 , H3N2 , Flu B within 3 month precede enrolment trial Vaccination influenza past 6 month precede enrolment trial History bronchial asthma , chronic lung disease , chronic rhinitis History immunodeficiency state History immunosuppression &lt; 6 month prior immunization History anaphylactic allergic reaction influenza vaccine vaccine component excipient ( e.g . gentamicin thimerosal ) Acute infectious fever &gt; 38 degree Celsius noninfectious disease ( within 72 hour ) precede enrollment trial The volunteer take immunoglobulin product blood transfusion past 3 month begin experiment Participation research study Pregnancy plan become pregnant 60 day enrollment breast feed Current alcohol abuse drug addiction might interfere ability comply trial procedure Any condition opinion investigator would pose health risk subject enrol , could interfere evaluation vaccine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>GPO Tri Fluvac Vaccine</keyword>
	<keyword>Tri Fluvac Vaccine</keyword>
</DOC>